Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Olfactomics is a Finnish private deeptech and medical device company developing differential mobility spectrometry-based solutions for medical and industrial gas analysis. Its lead healthcare product, Olfactomics Resect, is designed for intraoperative surgical margin assessment by analyzing surgical smoke in real time, with an initial focus on breast-conserving cancer surgery. The company also markets the IonVision platform for broader volatile organic compound analysis across industrial and life science applications. Olfactomics appears to operate as a platform-oriented diagnostics/device company rather than a therapeutic developer, combining proprietary gas sensing hardware with data analytics and machine learning. The company is headquartered in Tampere, Finland, and originated as a university-based spinout.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Olfactomics.